An indirect role for NK cells in a CD4 T-cell-dependent mouse model of type i diabetes

Immunology and Cell Biology

Volumn 90, Issue 2, 2012, Pages 243-247

  Angstetra, Eveline ^a   Graham, Kate L ^a   Zhao, Yuxing ^a   Irvin, Allison E ^a   Elkerbout, Lorraine ^a   Santamaria, Pere ^c   Slattery, Robyn M ^d   Kay, Thomas W ^a,b   Thomas, Helen E ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF CALGARY   (Canada)

^d MONASH UNIVERSITY   (Australia)

Author keywords

cytotoxicity; NK cells; type I diabetes

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DIABETOGENESIS; EFFECTOR CELL; EXPERIMENTAL MODEL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE TRANSFER; LYMPHOCYTIC INFILTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET BETA CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DIABETES MELLITUS, TYPE 1; HLA-A ANTIGENS; INSULIN-SECRETING CELLS; KILLER CELLS, NATURAL; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; RECEPTORS, INTERLEUKIN-2;

MUS;

EID: 84857029782     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.16     Document Type: Article

References (27)

1. Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest 2000; 105: 459-468. (Pubitemid 30127246)
2. Angstetra E, Graham KL, Emmett S, Dudek NL, Darwiche R, Ayala-Perez R et al. In vivo effects of cytokines on pancreatic beta-cells in models of type I diabetes dependent on CD4(+) T lymphocytes. Immunol Cell Biol 2009; 87: 178-185.
3. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23: 225-274. (Pubitemid 40563170)
4. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3: 781-790. (Pubitemid 37328656)
5. Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Samtamaria P, Bluestone JA et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004; 20: 757-767. (Pubitemid 38757445)
6. Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N et al. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat Immunol 2010; 11: 121-128.
7. Hamilton-Williams EE, Palmer SE, Charlton B, Slattery RM. Beta cell MHC class I is a late requirement for diabetes. Proc Natl Acad Sci USA 2003; 100: 6688-6693. (Pubitemid 36666642)
8. Kanagawa O, Militech A, Vaupel BA. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice. J Immunol 2002; 168: 6159-6164. (Pubitemid 34620034)
9. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005; 174: 6477-6489. (Pubitemid 40663843)
10. Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009; 31: 654-664.
11. Poirot L, Benoist C, Mathis D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc Natl Acad Sci USA 2004; 101: 8102-8107. (Pubitemid 38698061)
12. Alba A, Planas R, Clemente X, Carrillo J, Ampudia R, Puertas MC et al. Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta. Clin Exp Immunol 2008; 151: 467-475. (Pubitemid 351160730)
13. Maruyama T, Watanabe K, Takei I, Kasuga A, Shimada A, Yanagawa T et al. Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice. Diabetes Res 1991; 17: 37-41.
14. Maruyama T, Watanabe K, Yanagawa T, Kasatani T, Kasuga A, Shimada A et al. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice. Diabetes Res 1991; 16: 171-175.
15. Flodstrom-Tullberg M. Viral infections: their elusive role in regulating susceptibility to autoimmune disease. Microbes Infect 2003; 5: 911-921. (Pubitemid 36959940)
16. Dudek NL, Thomas HE, Mariana L, Sutherland RM, Allison J, Estella E et al. Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes 2006; 55: 2412-2418. (Pubitemid 44871141)
17. McKenzie MD, Dudek NL, Mariana L, Chong MM, Trapani JA, Kay TW et al. Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL. Int Immunol 2006; 18: 837-846. (Pubitemid 43983279)
18. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 1260-1265. (Pubitemid 41057741)
19. Morandi B, Bougras G, Muller WA, Ferlazzo G, Munz C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur J Immunol 2006; 36: 2394-2400. (Pubitemid 44420596)
20. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993; 178: 567-577. (Pubitemid 23218205)
21. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J ExpMed 2002; 195: 327-333. (Pubitemid 34461490)
22. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002; 195: 335-341. (Pubitemid 34461491)
23. Brauner H, Elemans M, Lemos S, Broberger C, Holmberg D, Flodstrom-Tullberg M et al. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J Immunol 2010; 184: 2272-2280.
24. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 1997; 186: 1663-1676. (Pubitemid 27506280)
25. Katz JD, Wang B, Haskins K, Benoist C, Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993; 74: 1089-1100. (Pubitemid 23289465)
26. Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol 1996; 157: 3688-3693. (Pubitemid 126449185)
27. Kiessling R, Klein E, Pross H, Wigzell H. 'Natural' killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975; 5: 117-121.